The Importance of Packaging and Labeling in Pharmaceutical Product Development

Michael Esposito Instructor:
Michael Esposito 
Monday, August 12, 2024
10:00 AM PDT | 01:00 PM EDT
90 Minutes
Webinar ID: 502321

More Trainings by this Expert

Price Details
Live Webinar
$149 One Attendee
$299 Corporate Live
Recorded Webinar
$199 One Attendee
$399 Corporate Recorded
Combo Offers
Live + Recorded
$299 $348 Live + Recorded
Corporate (Live + Recorded)
$599 $698 Corporate
(Live + Recorded)

Live: One Dial-in One Attendee

Corporate Live: Any number of participants

Recorded: Access recorded version, only for one participant unlimited viewing for 6 months ( Access information will be emailed 24 hours after the completion of live webinar)

Corporate Recorded: Access recorded version, Any number of participants unlimited viewing for 6 months ( Access information will be emailed 24 hours after the completion of live webinar)

Overview:

Occupying a critical position in the success or failure of any pharmaceutical product launch, Packaging and Labeling form a bridge between the conception of a product and its realization and distribution.

Their activities are also crucial for compliance with regulatory agency requirements.

Still, their importance is often underestimated, especially in the planning phases, which leads to unnecessary increases in cycle time, costly errors, and delays in product availability, or product recalls due to noncompliance. Understanding the packaging and labeling process in the larger product development process will provide you an advantage in achieving success.

Why you should Attend: Pharmaceutical and life sciences companies are under an extreme amount of pressure to comply with an ever-increasing amount of regulation and legislation. With this pressure, they still need to increase efficiencies, bring new products to the market faster, reduce prices, deliver innovation, ensure patient compliance, and maintain business compliance. Packaging and Labeling activities are at the forefront of this effort, as much of their activity occurs shortly before product manufacture and distribution.

Areas Covered in the Session:

  • Regulatory Agency Requirements
  • SOPs and Change Control considerations related to packaging
  • Packaging and Labeling Interactions
  • Creation of the Package
  • Codes
  • Packaging Errors
  • Labeling Errors
  • Supply Chain Issues
  • Special Considerations (e.g. product launches, clinical vs. commercial packaging)

Who Will Benefit:
  • Marketing
  • Project Management
  • Operations
  • Regulatory Affairs
  • Labeling and Packaging
  • Quality Assurance
  • Production Control
  • Packaging Technology
  • Labeling Coordination
  • Package Engineers
  • Packaging Operations
  • Sales and Marketing
  • Quality Assurance Consultants
  • Research and Development


Speaker Profile
Michael Esposito has over 30 years experience in the pharmaceutical industry and 17 years experience in GMP training and document management. He has worked for Wyeth Pharmaceuticals, Pfizer and Johnson & Johnson's McNeil Consumer Healthcare Division in a variety of areas including Packaging, project administration, Quality Assurance, Government Contracts, translations, systems training, and international operations.

He collaborated in the development and implementation of the training portion of the Consent Decree workplan for McNeil and revised their introductory GMP course. He is a member of the training organizations GMP Training Educators Association and Association for GXP Excellence (AGXPE) and is fully fluent in Spanish. His areas of interest include systems training, training effectiveness, post-training user support, process improvement, and sustainable packaging.


You Recently Viewed

Subscribe to our Newsletter

Subscribe for Compliance Alerts Research Reports Absolutely Free